VIP-ellipticine derivatives inhibit the growth of breast cancer cells
- 14 May 2002
- journal article
- Published by Elsevier in Life Sciences
- Vol. 71 (9) , 1005-1014
- https://doi.org/10.1016/s0024-3205(02)01741-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cellsBreast Cancer Research and Treatment, 2001
- Cytotoxic agents directed to peptide hormone receptors: Defining the requirements for a successful drugProceedings of the National Academy of Sciences, 1998
- Peptides and growth factors in non-small cell lung cancerPeptides, 1996
- Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathwaysJournal of Molecular Medicine, 1996
- Recombinant immunotoxinsBreast Cancer Research and Treatment, 1996
- Multiple receptors for PACAP and VIPTrends in Pharmacological Sciences, 1994
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.Proceedings of the National Academy of Sciences, 1993
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970